Literature DB >> 18757654

Accuracy of self-screening for contraindications to combined oral contraceptive use.

Daniel Grossman1, Leticia Fernandez, Kristine Hopkins, Jon Amastae, Sandra G Garcia, Joseph E Potter.   

Abstract

OBJECTIVE: To estimate how well a convenience sample of women from the general population could self-screen for contraindications to combined oral contraceptives using a medical checklist.
METHODS: Women 18-49 years old (N=1,271) were recruited at two shopping malls and a flea market in El Paso, Texas, and asked first whether they thought birth control pills were medically safe for them. They then used a checklist to determine the presence of level 3 or 4 contraindications to combined oral contraceptives according to the World Health Organization Medical Eligibility Criteria. The women then were interviewed by a blinded nurse practitioner, who also measured blood pressure.
RESULTS: The sensitivity of the unaided self-screen to detect true contraindications was 56.2% (95% confidence interval [CI] 51.7-60.6%), and specificity was 57.6% (95% CI 54.0-61.1%). The sensitivity of the checklist to detect true contraindications was 83.2% (95% CI 79.5-86.3%), and specificity was 88.8% (95% CI 86.3-90.9%). Using the checklist, 6.6% (95% CI 5.2-8.0%) of women incorrectly thought they were eligible for use when, in fact, they were contraindicated, largely because of unrecognized hypertension. Seven percent (95% CI 5.4-8.2%) of women incorrectly thought they were contraindicated when they truly were not, primarily because of misclassification of migraine headaches. In regression analysis, younger women, more educated women, and Spanish speakers were significantly more likely to correctly self-screen (P<.05).
CONCLUSION: Self-screening for contraindications to oral contraceptives using a medical checklist is relatively accurate. Unaided screening is inaccurate and reflects common misperceptions about the safety of oral contraceptives. Over-the-counter provision of this method likely would be safe, especially for younger women and if independent blood pressure screening were encouraged.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18757654      PMCID: PMC2615461          DOI: 10.1097/AOG.0b013e31818345f0

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  12 in total

1.  Summary health statistics for U.S. adults: National Health Interview Survey, 1998.

Authors:  John R Pleis; Richard Coles
Journal:  Vital Health Stat 10       Date:  2002-12

2.  Barriers to contraceptive use in product labeling and practice guidelines.

Authors:  Daniel Grossman; Charlotte Ellertson; Katrina Abuabara; Kelly Blanchard; Francisco T Rivas
Journal:  Am J Public Health       Date:  2006-01-31       Impact factor: 9.308

3.  Over-the-counter access, changing WHO guidelines, and contraindicated oral contraceptive use in Mexico.

Authors:  Sara E Yeatman; Joseph E Potter; Daniel A Grossman
Journal:  Stud Fam Plann       Date:  2006-09

4.  Contraindications to oral contraceptive use among women in the United States, 1999-2001.

Authors:  Emily Shortridge; Kate Miller
Journal:  Contraception       Date:  2007-03-26       Impact factor: 3.375

5.  Agreement between women's and providers' assessment of hormonal contraceptive risk factors.

Authors:  Solmaz Shotorbani; Leslie Miller; David K Blough; Jacqueline Gardner
Journal:  Contraception       Date:  2006-03-20       Impact factor: 3.375

6.  Index for rating diagnostic tests.

Authors:  W J YOUDEN
Journal:  Cancer       Date:  1950-01       Impact factor: 6.860

7.  Reproductive risks in a community-based distribution program of oral contraceptives, Matamoros, Mexico.

Authors:  A S Zavala; M Perez-Gonzales; P Miller; M Welsh; L R Wilkens; M Potts
Journal:  Stud Fam Plann       Date:  1987 Sep-Oct

8.  Use of contraception and use of family planning services in the United States: 1982-2002.

Authors:  William D Mosher; Gladys M Martinez; Anjani Chandra; Joyce C Abma; Stephanie J Willson
Journal:  Adv Data       Date:  2004-12-10

9.  Pharmacist prescribing of hormonal contraceptives: results of the Direct Access study.

Authors:  Jacqueline S Gardner; Leslie Miller; Donald F Downing; Stephanie Le; David Blough; Solmaz Shotorbani
Journal:  J Am Pharm Assoc (2003)       Date:  2008 Mar-Apr

10.  Should oral contraceptives be available without prescription?

Authors:  J Trussell; F Stewart; M Potts; F Guest; C Ellertson
Journal:  Am J Public Health       Date:  1993-08       Impact factor: 9.308

View more
  24 in total

1.  Combined hormonal contraception use in reproductive-age women with contraindications to estrogen use.

Authors:  Julianne R Lauring; Erik B Lehman; Timothy A Deimling; Richard S Legro; Cynthia H Chuang
Journal:  Am J Obstet Gynecol       Date:  2016-04-05       Impact factor: 8.661

2.  Contraindications to progestin-only oral contraceptive pills among reproductive-aged women.

Authors:  Kari White; Joseph E Potter; Kristine Hopkins; Leticia Fernández; Jon Amastae; Daniel Grossman
Journal:  Contraception       Date:  2012-02-24       Impact factor: 3.375

3.  Physician attitudes toward over the counter availability for oral contraceptives.

Authors:  David L Howard; Jeffrey Wall; Julie L Strickland
Journal:  Matern Child Health J       Date:  2013-12

4.  Contraindications to combined oral contraceptives among over-the-counter compared with prescription users.

Authors:  Daniel Grossman; Kari White; Kristine Hopkins; Jon Amastae; Michele Shedlin; Joseph E Potter
Journal:  Obstet Gynecol       Date:  2011-03       Impact factor: 7.661

5.  Clinic versus over-the-counter access to oral contraception: choices women make along the US-Mexico border.

Authors:  Joseph E Potter; Kari White; Kristine Hopkins; Jon Amastae; Daniel Grossman
Journal:  Am J Public Health       Date:  2010-04-15       Impact factor: 9.308

6.  Pharmacist prescription of hormonal contraception in Oregon: Baseline knowledge and interest in provision.

Authors:  Maria I Rodriguez; K John McConnell; Jonas Swartz; Alison B Edelman
Journal:  J Am Pharm Assoc (2003)       Date:  2016 Sep-Oct

7.  Bills as Band-Aids: Hopes and Challenges of Expanding Pharmacists' Prescriptive Authority to Include Contraceptives.

Authors:  Kathrine Bendtsen
Journal:  HEC Forum       Date:  2019-12

8.  Perceptions of the safety of oral contraceptives among a predominantly Latina population in Texas.

Authors:  Daniel Grossman; Leticia Fernández; Kristine Hopkins; Jon Amastae; Joseph E Potter
Journal:  Contraception       Date:  2009-10-29       Impact factor: 3.375

9.  Medical contraindications to estrogen and contraceptive use among women veterans.

Authors:  Colleen P Judge; Xinhua Zhao; Florentina E Sileanu; Maria K Mor; Sonya Borrero
Journal:  Am J Obstet Gynecol       Date:  2017-10-27       Impact factor: 8.661

10.  Computer-assisted provision of hormonal contraception in acute care settings.

Authors:  Eleanor B Schwarz; Elizabeth J Burch; Sara M Parisi; Kathleen P Tebb; Daniel Grossman; Ateev Mehrotra; Ralph Gonzales
Journal:  Contraception       Date:  2012-08-24       Impact factor: 3.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.